Multiple forms of anti-acetylcholine receptor antibody in myasthenia gravis

Muscle & Nerve
T W MittagG Genkins

Abstract

Sera of patients with myasthenia gravis (MG) contain anti-acetylcholine receptor (AChR) IgG antibodies (Ab) which have different antigenic specificities. Three Ab types were detected: (1) MG-I, which forms immune complexes with AChR; (2) MG-C, which decreases binding of AChR to concanavalin A; and MG-B, which blocks alpha-bungarotoxin binding to AChR. Sera from 152 MG patients were screened for the Ab types. Sixty-one percent contained MG-I, 26% contained MG-C, 10% contained MG-B, and 5% contained both MG-C and MG-B. The latter Ab types were associated with more severe forms of MG but showed no other clinical correlations. IgG antibodies of defined type were purified, and their interaction with unlabeled and toxin-prelabeled AChR from denervated rat muscle was studied in detail. Receptors are homogeneous with respect to determinants recognized by MG-I, but heterogeneous with respect to determinants recognized by MG-C (3 subpopulations, 22%, 28%, and 50% of AChR) and by MG-B (2 subpopulations, 30% and 70% of AChR). The stoichiometry of AChR interaction with the antibodies indicates that for each toxin-binding site, the receptor is divalent as an antigen for MG-I and MG-C but is tetravalent for MG-B. Denervated muscle AChR appear...Continue Reading

References

Jan 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·C B Weinberg, Z W Hall
Jan 1, 1976·Advances in Protein Chemistry·P Cuatrecasas, M D Hollenberg
May 1, 1975·The Journal of Cell Biology·P N Devreotes, D M Fambrough
May 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·S H AppelS Elias
Oct 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·S C FroehnerZ W Hall
May 18, 1978·The New England Journal of Medicine·D B DrachmanG J Hoffman
Apr 1, 1978·Scandinavian Journal of Immunology·R Heimer, G Klein
Jan 20, 1977·The New England Journal of Medicine·K V ToykaI Kao
Nov 24, 1977·The New England Journal of Medicine·P C DauL E Spitler
Jan 1, 1976·Annals of the New York Academy of Sciences·J M LindstromS Whittingham
Jun 1, 1975·The Journal of Experimental Medicine·V A LennonM E Seybold
Oct 9, 1975·The New England Journal of Medicine·S H AppelN Levy
Dec 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·J PatrickJ McMillan
May 25, 1973·Science·J Patrick, J Lindstrom
Jul 25, 1972·Biochemical and Biophysical Research Communications·G S David

❮ Previous
Next ❯

Citations

Jan 1, 1992·Journal of Clinical Apheresis·P KornfeldM Mahjoub
Jan 1, 1989·Journal of Neuroimmunology·B Vernet-der GarabedianE Morel
Jan 1, 1981·Clinical Neurology and Neurosurgery·H J Oosterhuis
Jan 1, 1985·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·G S Sohal, T R Swift
Nov 1, 1984·Annals of Neurology·A G Engel
Dec 1, 1986·Acta Neurologica Scandinavica·S ThorlaciusO Tönder
May 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·N ShibuyaS Kawanami
Aug 1, 1985·Postgraduate Medical Journal·A K Mier, C W Havard
Jan 1, 1981·Annals of the New York Academy of Sciences·T MittagG Genkins
Apr 16, 1984·Klinische Wochenschrift·I KaliesJ R Kalden

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.